PMID- 38000011
OWN - NLM
STAT- MEDLINE
DCOM- 20231127
LR  - 20231127
IS  - 1473-2300 (Electronic)
IS  - 0300-0605 (Print)
IS  - 0300-0605 (Linking)
VI  - 51
IP  - 11
DP  - 2023 Nov
TI  - Evaluation of endovascular treatment of chronic limb-threatening ischemia for 
      patients in the PLAN gray zone.
PG  - 3000605231211768
LID - 10.1177/03000605231211768 [doi]
LID - 03000605231211768
AB  - OBJECTIVE: To compare the results of endovascular therapy for chronic 
      limb-threatening ischemia (CLTI) in patients categorized under the gray and 
      yellow zones of the patient risk, limb severity, and anatomic pattern (PLAN) 
      concept over a 2-year follow-up period. METHODS: Patients who underwent 
      endovascular therapy for peripheral artery disease and presented with CLTI from 
      February 2017 to February 2019 were retrospectively reviewed. The patients were 
      grouped into yellow and gray zones based on the PLAN concept. Preoperative and 
      postoperative walking distances, Rutherford classes, and postoperative target 
      vessel patency rates were recorded and compared between the groups. Follow-up 
      evaluations were performed at 1, 6, 12, and 24 months post-procedure. RESULTS: Of 
      the 387 patients evaluated, the yellow and gray groups comprised 88 patients 
      each. The overall patency rates were similar between the groups (84 (95.45%) vs. 
      81 (92.05%), respectively). The occlusion-/stenosis-free survival times, 
      amputation-free survival time, and mean survival time were not significantly 
      different. However, the gray group had a significantly higher number of 
      atherectomy interventions (74 vs. 59) and crosser devices used (62 vs. 42). 
      CONCLUSION: Endovascular therapy is an effective treatment option for patients in 
      the gray zone of the PLAN color coding system.
FAU - Budak, Ali Baran
AU  - Budak AB
AUID- ORCID: 0000-0002-9772-1765
AD  - Department of Cardiovascular Surgery, Ulus Liv Hospital, Besiktas-Istanbul, 
      Turkiye.
FAU - Altinay, Levent
AU  - Altinay L
AD  - Department of Cardiovascular Surgery, Diskapi Yildirim Beyazit Training and 
      Research Hospital, Ankara, Turkiye.
FAU - Gunertem, Orhan Eren
AU  - Gunertem OE
AD  - Department of Cardiovascular Surgery, Batikent Medical Park Hospital, Batikent, 
      Turkiye.
FAU - Saglam, Muhammet Sefa
AU  - Saglam MS
AD  - Department of Cardiovascular Surgery, Nigde Training and Research Hospital, 
      Nigde, Turkiye.
FAU - Kulahcioglu, Emre
AU  - Kulahcioglu E
AD  - Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkiye. 
      RINGGOLD: 536164
FAU - Tumer, Naim Boran
AU  - Tumer NB
AD  - Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkiye. 
      RINGGOLD: 536164
FAU - Yagiz, Betul Keskinkilic
AU  - Yagiz BK
AD  - Department of General Surgery, Samsun Gazi State Hospital, Samsun, Turkiye.
FAU - Terzioglu, Serdar Gokay
AU  - Terzioglu SG
AD  - Department of General Surgery, Ankara City Hospital, Ankara, Turkiye. RINGGOLD: 
      536164
FAU - Saba, Tonguc
AU  - Saba T
AD  - Department of Cardiovascular Surgery, Baskent University Hospital Alanya, 
      Alanya-Antalya, Turkiye.
FAU - Ozisik, Kanat
AU  - Ozisik K
AD  - Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkiye. 
      RINGGOLD: 536164
FAU - Gunaydin, Serdar
AU  - Gunaydin S
AD  - Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkiye. 
      RINGGOLD: 536164
LA  - eng
PT  - Journal Article
PL  - England
TA  - J Int Med Res
JT  - The Journal of international medical research
JID - 0346411
SB  - IM
MH  - Humans
MH  - Chronic Limb-Threatening Ischemia
MH  - Retrospective Studies
MH  - *Endovascular Procedures
MH  - Risk Factors
MH  - Ischemia/surgery
MH  - *Peripheral Arterial Disease/surgery
MH  - Treatment Outcome
MH  - Chronic Disease
PMC - PMC10676071
OTO - NOTNLM
OT  - PLAN color coding system
OT  - Peripheral arterial disease
OT  - atherectomy
OT  - chronic limb-threatening ischemia
OT  - endovascular procedure
OT  - limb salvage
COIS- Declaration of conflicting interestsThe authors declare that there is no conflict 
      of interest.
EDAT- 2023/11/24 18:42
MHDA- 2023/11/27 12:44
PMCR- 2023/11/24
CRDT- 2023/11/24 13:43
PHST- 2023/11/27 12:44 [medline]
PHST- 2023/11/24 18:42 [pubmed]
PHST- 2023/11/24 13:43 [entrez]
PHST- 2023/11/24 00:00 [pmc-release]
AID - 10.1177_03000605231211768 [pii]
AID - 10.1177/03000605231211768 [doi]
PST - ppublish
SO  - J Int Med Res. 2023 Nov;51(11):3000605231211768. doi: 10.1177/03000605231211768.